Shukra Pharmaceuticals Ltd - Stock Price

  • NSE :
  • BSE : 524632
  • ISIN CODE : INE551C01028
  • Industry : Pharmaceuticals & Drugs
  • House : Private
Shukra Pharmaceuticals Ltd is not traded on BSE/NSE
BSE
33.40
-4.98 %-1.75

Ratios

Parameter MAR 18  MAR 17  YoY %Change
Operational & Financial Ratios
   Earnings Per Share (Rs)3.363.214.56
   CEPS(Rs)8.066.1930.34
   DPS(Rs)0.500.500.00
   Book NAV/Share(Rs)95.8693.102.96
   Tax Rate(%)44.4452.49-15.33
Margin Ratios
   Core EBITDA Margin(%)28.0128.43-1.48
   EBIT Margin(%)17.1120.66-17.17
   Pre Tax Margin(%)16.4120.54-20.13
   PAT Margin (%)9.129.76-6.60
   Cash Profit Margin (%)21.9018.8116.44
Performance Ratios
   ROA(%)2.442.78-12.01
   ROE(%)3.553.511.25
   ROCE(%)5.947.41-19.80
   Asset Turnover(x)0.270.28-5.80
   Sales/Fixed Asset(x)0.240.25-1.38
   Working Capital/Sales(x)1.030.966.94
Efficiency Ratios
   Fixed Capital/Sales(x)4.114.051.40
   Receivable days170.95120.9241.38
   Inventory Days14.5926.67-45.29
   Payable days154.0783.1285.36
Valuation Parameters
   PER(x)18.3824.52-25.06
   PCE(x)7.6512.73-39.89
   Price/Book(x)0.640.85-23.90
   Yield(%)0.810.6327.63
   EV/Net Sales(x)2.472.316.98
   EV/Core EBITDA(x)7.637.74-1.40
   EV/EBIT(x)13.3611.1320.03
   EV/CE(x)0.550.63-12.55
   M Cap / Sales1.812.40-24.69
Growth Ratio
   Net Sales Growth(%)4.036.46-37.63
   Core EBITDA Growth(%)12.8711.5211.71
   EBIT Growth(%)-7.29202.64-103.60
   PAT Growth(%)4.56321.94-98.58
   EPS Growth(%)4.56321.94-98.58
Financial Stability Ratios
   Total Debt/Equity(x)0.240.009567.71
   Current Ratio(x)3.114.12-24.55
   Quick Ratio(x)3.053.93-22.40
   Interest Cover(x)24.45182.99-86.64
   Total Debt/Mcap(x)0.370.0012604.51

Latest News

close